Articles

Supporting a CAR-T Therapy for Multiple Myeloma with Integrated Laboratory Testing and Clinical Expertise

An emerging biotech sponsor chose Covance by Labcorp (Covance) to support clinical testing and trials in their early-phase multiple myeloma study with a novel CAR-T therapy. Learn how the sponsor extended their team's expertise - through the Covance multiple myeloma team and CAR-T working group - and recognized the benefits of an integrated approach that united both laboratory services and clinical trial support to increase transparency and gain efficiencies across their portfolio.